prazosin BPH
Selected indexed studies
- alpha1- and alpha2-adrenoceptors in BPH. (Eur Urol, 1999) [PMID:10393470]
- Alpha blocker prazosin for the treatment of benign prostatic hypertrophy (BPH). (J Postgrad Med, 1995) [PMID:10707729]
- Clinical ease of using doxazosin in BPH patients with and without hypertension. (Prostate Cancer Prostatic Dis, 2005) [PMID:15711605]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Clinical ease of using doxazosin in BPH patients with and without hypertension. (2005) pubmed
- The efficacy and safety of terazosin for the treatment of symptomatic BPH. (1991) pubmed
- Terazosin for BPH. (1995) pubmed
- alpha1- and alpha2-adrenoceptors in BPH. (1999) pubmed
- Alpha blocker prazosin for the treatment of benign prostatic hypertrophy (BPH). (1995) pubmed
- How many drugs for LUTS due to BPH are too many? (2008) pubmed
- Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia. (2000) pubmed
- Treatment and pharmacologic management of BPH in the context of common comorbidities. (2006) pubmed
- How do symptoms indicative of BPH progress in real life practice? The UK experience. (2000) pubmed
- Benign prostatic hyperplasia. Current pharmacological treatment. (1994) pubmed